Last reviewed · How we verify
Misoprostol Oral Product
At a glance
| Generic name | Misoprostol Oral Product |
|---|---|
| Also known as | Oral Product |
| Sponsor | University of Wisconsin, Madison |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion (NA)
- Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening (PHASE3)
- PROMMO Trial: Oral Misoprostol vs IV Oxytocin (EARLY_PHASE1)
- Induction of Labour at Term With Low Dose Oral Misoprostol Versus a Foley Catheter (PHASE4)
- A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour Induction (PHASE4)
- Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages (PHASE3)
- Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss (PHASE4)
- Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Misoprostol Oral Product CI brief — competitive landscape report
- Misoprostol Oral Product updates RSS · CI watch RSS
- University of Wisconsin, Madison portfolio CI